Subscribe to information
Subscribe to information
Press releases
Investor letters (in Swedish)
2022
December
Ett år enligt plan mot en kommersiell produkt
2021
December
Med siktet inställt på målet
2020
December
Full fart framåt
Presentations (in Swedish)
2021-05-26
Godmorgon Lund (12.00)
2021-05-26
Aktieportföljen Live
2021-01-20
G&W Digitala Småbolagsfrukost
Media bank
Images of the management team
NanoEcho in media (in Swedish)
Med ambition att förbättra diagnostisering av ändtarmscancer
(Morgondagens samhälle, bilaga till SvD, 2021-10)
Banbrytande teknik revolutionerar diagnostik av rektalcancerpatienter
(Kampen mot cancer, 2021-02)
NanoEcho tar in 34 miljoner
(Rapidus, 2020-11)
… och portföljbolaget tar in 17 miljoner
(Rapidus, 2020-05)
NanoEcho’s innovative method, with its high precision, aims to facilitate the differentiation between diseased and healthy tissue and at the same time determine a more precise localization of cancerous tissue. The goal is to be able to provide a more precise, simpler and more cost-effective diagnosis of, among other things, cancer diseases.
NanoEcho AB
Gasverksgatan 1
222 29 Lund
info@nanoecho.se
We use cookies to enhance your experience on our website and analyze our traffic. By clicking ‘Accept,’ you consent to our use of cookies. You can learn more about the types of cookies we use and how to manage them in our privacy policy.